The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I (Ph1) study of dasatinib (D) with cetuximab (Cet) /radiation (IMRT) +/- cisplatin (P) in stage II, III/IV head and neck squamous cell carcinoma (HNSCC).
 
Shanthi Marur
Research Funding - Bristol-Myers Squibb
 
Hao Wang
No Relationships to Disclose
 
Harry Quon
No Relationships to Disclose
 
Christine H. Chung
Consulting or Advisory Role - Novartis
Research Funding - Boehringer Ingelheim; Immunogen
Travel, Accommodations, Expenses - Merck
 
Maura L. Gillison
No Relationships to Disclose
 
Nishant Agrawal
No Relationships to Disclose
 
Jeremy Richmon
No Relationships to Disclose
 
Rathan M. Subramaniam
Consulting or Advisory Role - Philips Healthcare
 
Wayne Koch
No Relationships to Disclose
 
Christine Gail Gourin
No Relationships to Disclose
 
Arlene A. Forastiere
Employment - Eviti
Stock and Other Ownership Interests - Eviti